Appl Clin Inform 2019; 10(03): 513-520
DOI: 10.1055/s-0039-1693426
Research Article
Georg Thieme Verlag KG Stuttgart · New York

Development and Evaluation of a Clinical Decision Support System to Improve Medication Safety

Sara Ibáñez-Garcia
1   Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
,
Carmen Rodriguez-Gonzalez
1   Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
,
Vicente Escudero-Vilaplana
1   Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
,
Maria Luisa Martin-Barbero
1   Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
,
Belén Marzal-Alfaro
1   Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
,
Jose Luis De la Rosa-Triviño
2   Ysengineers S.L., Málaga, Spain
,
Irene Iglesias-Peinado
3   Pharmacology Department, College of Pharmacy, Complutense University of Madrid, Madrid, Spain
,
Ana Herranz-Alonso
1   Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
,
Maria Sanjurjo Saez
1   Instituto de Investigación Sanitaria del Hospital Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
› Author Affiliations
Funding This project was supported by iPharma (Pharmacy Innovation Center) through funding received with project PI12/02883 (Instituto de Salud Carlos III).
Further Information

Publication History

23 January 2019

06 June 2019

Publication Date:
17 July 2019 (online)

Abstract

Background Clinical decision support systems (CDSSs) are a good strategy for preventing medication errors and reducing the incidence and severity of adverse drug events (ADEs). However, these systems are not very effective and are subject to multiple limitations that prevent their implementation in clinical practice.

Objectives The objective of this study was to evaluate the effectiveness of an advanced CDSS, HIGEA, which generates alerts based on predefined clinical rules to identify patients at risk of an ADE.

Methods A multidisciplinary team defined the system and the clinical rules focusing on medication errors commonly encountered in clinical practice. Four intervention programs were defined: (1) dose adjustment in renal impairment; (2) adjustment of anticoagulation/antiplatelet therapy; (3) detection of biochemical/hematologic toxicities; and (4) therapeutic drug monitoring. We performed a 6-month observational prospective study to analyze the effectiveness of these clinical rules by calculating the positive predictive value (PPV).

Results The team defined 211 clinical rules. During the study period, HIGEA generated 1,086 alerts (8.9 alerts per working day), which were reviewed by pharmacists. Fifty-one percent (554/1,086) of alerts generated an intervention to prevent a possible ADE; of these, 66% (368/554) required a documented modification to therapy owing to a real prescription error intercepted. The intervention program that induced the highest number of modifications to therapy was the dose adjustment in renal impairment program (PPV = 0.51), followed by the adjustment of anticoagulation/antiplatelet therapy program (PPV = 0.24). The percentage of accepted interventions was similar in surgical units (68%), medical units (67%), and critical care units (63%).

Conclusion Our study offers evidence that HIGEA is highly effective in preventing potential ADEs at the prescription stage.

Protection of Human and Animal Subjects

This study was performed in compliance with the World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Human Subjects and was reviewed by Gregorio Marañón Hospital Institutional Review Board.


Supplementary Material

 
  • References

  • 1 Kohn LTCJ, Donaldson MS. To Err is Human: Building a Safer Health System. Washington, DC: National Academy Press; 1999
  • 2 Leape LL, Brennan TA, Laird N. , et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991; 324 (06) 377-384
  • 3 Bates DW, Cullen DJ, Laird N. , et al; ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 1995; 274 (01) 29-34
  • 4 Leape LL, Bates DW, Cullen DJ. , et al; ADE Prevention Study Group. Systems analysis of adverse drug events. JAMA 1995; 274 (01) 35-43
  • 5 Bobb A, Gleason K, Husch M, Feinglass J, Yarnold PR, Noskin GA. The epidemiology of prescribing errors: the potential impact of computerized prescriber order entry. Arch Intern Med 2004; 164 (07) 785-792
  • 6 Lewis PJ, Dornan T, Taylor D, Tully MP, Wass V, Ashcroft DM. Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review. Drug Saf 2009; 32 (05) 379-389
  • 7 Franklin BD, Reynolds M, Shebl NA, Burnett S, Jacklin A. Prescribing errors in hospital inpatients: a three-centre study of their prevalence, types and causes. Postgrad Med J 2011; 87 (1033): 739-745
  • 8 Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003; 163 (12) 1409-1416
  • 9 Nuckols TK, Smith-Spangler C, Morton SC. , et al. The effectiveness of computerized order entry at reducing preventable adverse drug events and medication errors in hospital settings: a systematic review and meta-analysis. Syst Rev 2014; 3: 56
  • 10 Kuperman GJ, Bobb A, Payne TH. , et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007; 14 (01) 29-40
  • 11 Bright TJ, Wong A, Dhurjati R. , et al. Effect of clinical decision-support systems: a systematic review. Ann Intern Med 2012; 157 (01) 29-43
  • 12 Kaushal R, Jha AK, Franz C. , et al; Brigham and Women's Hospital CPOE Working Group. Return on investment for a computerized physician order entry system. J Am Med Inform Assoc 2006; 13 (03) 261-266
  • 13 Wolfstadt JI, Gurwitz JH, Field TS. , et al. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med 2008; 23 (04) 451-458
  • 14 Rommers MK, Zegers MH, De Clercq PA. , et al. Development of a computerised alert system, ADEAS, to identify patients at risk for an adverse drug event. Qual Saf Health Care 2010; 19 (06) e35
  • 15 Forster AJ, Jennings A, Chow C, Leeder C, van Walraven C. A systematic review to evaluate the accuracy of electronic adverse drug event detection. J Am Med Inform Assoc 2012; 19 (01) 31-38
  • 16 van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006; 13 (02) 138-147
  • 17 Azaz-Livshits T, Levy M, Sadan B, Shalit M, Geisslinger G, Brune K. Computerized surveillance of adverse drug reactions in hospital: pilot study. Br J Clin Pharmacol 1998; 45 (03) 309-314
  • 18 Tse CS, Madura AJ. An adverse drug reaction reporting program in a community hospital. QRB Qual Rev Bull 1988; 14 (11) 336-340
  • 19 Dalton-Bunnow MF, Halvachs FJ. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial. Hosp Pharm 1993; 28 (08) 746-749
  • 20 Levy M, Azaz-Livshits T, Sadan B, Shalit M, Geisslinger G, Brune K. Computerized surveillance of adverse drug reactions in hospital: implementation. Eur J Clin Pharmacol 1999; 54 (11) 887-892
  • 21 Tolley CL, Slight SP, Husband AK, Watson N, Bates DW. Improving medication-related clinical decision support. Am J Health Syst Pharm 2018; 75 (04) 239-246
  • 22 Phansalkar S, Zachariah M, Seidling HM, Mendes C, Volk L, Bates DW. Evaluation of medication alerts in electronic health records for compliance with human factors principles. J Am Med Inform Assoc 2014; 21 (e2): e332-e340
  • 23 Schiff GD, Klass D, Peterson J, Shah G, Bates DW. Linking laboratory and pharmacy: opportunities for reducing errors and improving care. Arch Intern Med 2003; 163 (08) 893-900
  • 24 Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA 1991; 266 (20) 2847-2851
  • 25 Honigman B, Lee J, Rothschild J. , et al. Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 2001; 8 (03) 254-266
  • 26 Jha AK, Kuperman GJ, Teich JM. , et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5 (03) 305-314
  • 27 Kane-Gill SL, Dasta JF, Schneider PJ, Cook CH. Monitoring abnormal laboratory values as antecedents to drug-induced injury. J Trauma 2005; 59 (06) 1457-1462
  • 28 Schiff GD, Aggarwal HC, Kumar S, McNutt RA. Prescribing potassium despite hyperkalemia: medication errors uncovered by linking laboratory and pharmacy information systems. Am J Med 2000; 109 (06) 494-497
  • 29 Szekendi MK, Sullivan C, Bobb A. , et al. Active surveillance using electronic triggers to detect adverse events in hospitalized patients. Qual Saf Health Care 2006; 15 (03) 184-190
  • 30 Silverman JB, Stapinski CD, Huber C, Ghandi TK, Churchill WW. Computer-based system for preventing adverse drug events. Am J Health Syst Pharm 2004; 61 (15) 1599-1603
  • 31 Wong A, Wright A, Seger DL, Amato MG, Fiskio JM, Bates D. Comparison of overridden medication-related clinical decision support in the intensive care unit between a commercial system and a legacy system. Appl Clin Inform 2017; 8 (03) 866-879
  • 32 Awdishu L, Coates CR, Lyddane A. , et al. The impact of real-time alerting on appropriate prescribing in kidney disease: a cluster randomized controlled trial. J Am Med Inform Assoc 2016; 23 (03) 609-616
  • 33 Tawadrous D, Shariff SZ, Haynes RB, Iansavichus AV, Jain AK, Garg AX. Use of clinical decision support systems for kidney-related drug prescribing: a systematic review. Am J Kidney Dis 2011; 58 (06) 903-914
  • 34 Jha AK, Laguette J, Seger A, Bates DW. Can surveillance systems identify and avert adverse drug events? A prospective evaluation of a commercial application. J Am Med Inform Assoc 2008; 15 (05) 647-653
  • 35 Kilbridge PMAL, Ahmad A. Implementation of a system for computerized adverse drug event surveillance and intervention at an Academic Medical Center. J Clin Outcomes Manag 2006; 13 (02) 94-100
  • 36 Nanji KC, Slight SP, Seger DL. , et al. Overrides of medication-related clinical decision support alerts in outpatients. J Am Med Inform Assoc 2014; 21 (03) 487-491
  • 37 Rommers MK, Zwaveling J, Guchelaar HJ, Teepe-Twiss IM. Evaluation of rule effectiveness and positive predictive value of clinical rules in a Dutch clinical decision support system in daily hospital pharmacy practice. Artif Intell Med 2013; 59 (01) 15-21
  • 38 Hospitalaria SEdF. 2020 Hacia el futuro con seguridad. Madrid: 2015
  • 39 Kane-Gill SL, MacLasco AM, Saul MI. , et al. Use of text searching for trigger words in medical records to identify adverse drug reactions within an intensive care unit discharge summary. Appl Clin Inform 2016; 7 (03) 660-671
  • 40 Boyce RD, Jao J, Miller T, Kane-Gill SL. Automated screening of emergency department notes for drug-associated bleeding adverse events occurring in older adults. Appl Clin Inform 2017; 8 (04) 1022-1030
  • 41 Nightingale PG, Adu D, Richards NT, Peters M. Implementation of rules based computerised bedside prescribing and administration: intervention study. BMJ 2000; 320 (7237): 750-753
  • 42 Bates DW, Gawande AA. Improving safety with information technology. N Engl J Med 2003; 348 (25) 2526-2534